• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Puma Biotechnology Inc - Common Stock (NQ:PBYI)

6.040 -0.010 (-0.17%)
Streaming Delayed Price Updated: 1:44 PM EDT, Mar 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Puma Biotechnology Inc - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Puma Biotechnology (NASDAQ:PBYI) Beats Q4 Estimates, Guides for Profitable 2026 ↗
February 26, 2026
Via Chartmill
News headline image
Puma Biotech (PBYI) Earnings Call Transcript ↗
February 26, 2026
Puma Biotech (PBYI) Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results
February 26, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology to Present at TD Cowen’s 46th Annual Health Care Conference
February 23, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Earnings Scheduled For November 6, 2025 ↗
November 06, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For August 7, 2025 ↗
August 07, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
May 08, 2025
 
Via Benzinga
News headline image
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results
February 12, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
February 04, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
January 07, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI)
December 22, 2025
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
December 02, 2025
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
November 10, 2025
 
Via Benzinga
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
November 07, 2025
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology (NASDAQ:PBYI) Tops Q3 2025 Estimates and Raises Full-Year Outlook ↗
November 06, 2025
Puma Biotech's Q3 2025 earnings beat expectations, driven by strong NERLYNX sales. The company raised its full-year revenue guidance and advances its clinical pipeline. 
Via Chartmill
Topics Earnings
News headline image
Puma Biotechnology Reports Third Quarter 2025 Financial Results
November 06, 2025
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results
October 23, 2025
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
October 02, 2025
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
September 04, 2025
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 02, 2025
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
August 08, 2025
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma (PBYI) Q2 Revenue Rises 11% ↗
August 08, 2025
Via The Motley Fool
Topics Intellectual Property
News headline image
Puma Biotechnology Reports Second Quarter Financial Results
August 07, 2025
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2025 Financial Results
July 24, 2025
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2025
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
June 04, 2025
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Reports First Quarter Financial Results
May 08, 2025
From Puma Biotechnology, Inc..
Via Business Wire
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
May 06, 2025
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Presents Clinical Data on Neratinib at the AACR Annual Meeting 2025
April 28, 2025
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2025 Financial Results
April 24, 2025
From Puma Biotechnology, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap